Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
SUVEN PHARMACEUTICALS TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SUVEN PHARMACEUTICALS Mar-23 |
TEVA PHARMA Dec-13 |
SUVEN PHARMACEUTICALS/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 629 | 3,483 | - | |
Low | Rs | 388 | 3,026 | - | |
Sales per share (Unadj.) | Rs | 52.7 | 1,998.8 | - | |
Earnings per share (Unadj.) | Rs | 16.2 | 124.9 | - | |
Cash flow per share (Unadj.) | Rs | 18.0 | 286.4 | - | |
Dividends per share (Unadj.) | Rs | 6.00 | 109.31 | - | |
Avg Dividend yield | % | 1.2 | 3.4 | 35.1% | |
Book value per share (Unadj.) | Rs | 68.2 | 2,220.3 | - | |
Shares outstanding (eoy) | m | 254.57 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 9.7 | 1.6 | 593.0% | |
Avg P/E ratio | x | 31.5 | 26.1 | 120.7% | |
P/CF ratio (eoy) | x | 28.2 | 11.4 | 248.1% | |
Price / Book Value ratio | x | 7.5 | 1.5 | 508.8% | |
Dividend payout | % | 37.1 | 87.5 | 42.4% | |
Avg Mkt Cap | Rs m | 129,395 | 2,759,528 | 4.7% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 1,105 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,712.8 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,355.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 13,403 | 1,695,000 | 0.8% | |
Other income | Rs m | 464 | 0 | - | |
Total revenues | Rs m | 13,867 | 1,695,000 | 0.8% | |
Gross profit | Rs m | 5,739 | 464,177 | 1.2% | |
Depreciation | Rs m | 477 | 137,008 | 0.3% | |
Interest | Rs m | 128 | 33,293 | 0.4% | |
Profit before tax | Rs m | 5,597 | 293,876 | 1.9% | |
Minority Interest | Rs m | 0 | 1,335 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,913 | -0.0% | |
Tax | Rs m | 1,484 | -3,588 | -41.4% | |
Profit after tax | Rs m | 4,113 | 105,885 | 3.9% | |
Gross profit margin | % | 42.8 | 27.4 | 156.4% | |
Effective tax rate | % | 26.5 | -1.2 | -2,172.2% | |
Net profit margin | % | 30.7 | 6.2 | 491.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,554 | 1,144,797 | 1.0% | |
Current liabilities | Rs m | 3,031 | 998,360 | 0.3% | |
Net working cap to sales | % | 63.6 | 8.6 | 736.0% | |
Current ratio | x | 3.8 | 1.1 | 332.4% | |
Inventory Days | Days | 148 | 91 | 163.5% | |
Debtors Days | Days | 302 | 96 | 315.0% | |
Net fixed assets | Rs m | 9,547 | 553,624 | 1.7% | |
Share capital | Rs m | 255 | 4,172 | 6.1% | |
Net worth | Rs m | 17,352 | 1,882,824 | 0.9% | |
Long term debt | Rs m | 46 | 866,691 | 0.0% | |
Total assets | Rs m | 21,101 | 3,873,619 | 0.5% | |
Interest coverage | x | 44.7 | 9.8 | 454.8% | |
Debt to equity ratio | x | 0 | 0.5 | 0.6% | |
Sales to assets ratio | x | 0.6 | 0.4 | 145.2% | |
Return on assets | % | 20.1 | 3.6 | 559.4% | |
Return on equity | % | 23.7 | 5.6 | 421.5% | |
Return on capital | % | 32.9 | 4.9 | 667.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 4,509 | 270,095 | 1.7% | |
From Investments | Rs m | -1,948 | -95,706 | 2.0% | |
From Financial Activity | Rs m | -2,358 | -323,998 | 0.7% | |
Net Cashflow | Rs m | 202 | -149,608 | -0.1% |
Compare SUVEN PHARMACEUTICALS With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare SUVEN PHARMACEUTICALS With: GSK PHARMA BROOKS LAB ADESHWAR MEDITEX FERMENTA BIOTECH KWALITY PHARMA
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.